BIT has only done animal trials, ACW has completed human trials with good safety data so BIT is a long way off commercialisation.
ACW has one (now two) MASSIVE markets desperate for solutions and a niche application in fragile X with no other competitors. BIT is pitching covid treatments where there are competitors in the market. They are already too late.
And BIT's market cap reflects this.
ACW's SP is depressed by the cap raise - an excellent time to buy.
BIT has only done animal trials, ACW has completed human trials...
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.006(15.8%) |
Mkt cap ! $74.46M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.4¢ | 2.9¢ | $186.2K | 6.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 189149 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 621429 | 4 |
View Market Depth
| Last trade - 15.52pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.2¢ |
Change
-0.006 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.4¢ | 2.9¢ | 3278602 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| ACW (ASX) Chart |